CAS 1808081-43-7

Gilvetmab

CAS: 1808081-43-7

Anti-PDCD1, PD1, CD279 monoclonal antibody

Ref: 3D-CLA1474

Gilvetmab

CAS: 1808081-43-7

Gilvetmab is a caninized anti-PD-1 antibody approved for veterinary use, researched for stage I-III mast cell tumors and stage II-III melanoma in dogs.

Reinheit: 95% - 97.9% (SDS-PAGE); 97.4% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: 147.95 kDa

Ref: TM-T77024